SignalXSignalX

CGON CG Oncology, Inc.

8-K Current Report
Filed: February 27, 2026
Health Care
Biological Products, (No Diagnostic Substances)
CG Oncology, Inc. Overview

CG Oncology, Inc. (CGON) 8-K current report filed with SEC EDGAR on February 27, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • CGON reported full-year and Q4 2025 financial results via press release dated February 27, 2026
  • • Actual figures in Exhibit 99.1 — filing itself contains no financial data; refer to attached press release for revenue, cash, and expense details

Get deeper insights on CG Oncology, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.